ClinicalTrials.Veeva

Menu

The Influence of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Renal Function in Patients Undergoing Non-emergent Coronary Angiography

S

Soroka University Medical Center

Status

Completed

Conditions

Blood Pressure

Treatments

Drug: ACE/ARB stopped 24 hours before procedure and start immediately after
Drug: stop ace-i/arb 24 h before procedure and restarted 24 hours after the procedure

Study type

Interventional

Funder types

Other

Identifiers

NCT01071642
sor495209ctil

Details and patient eligibility

About

The aim of the current study is to evaluate prospectively whether concomitant administration of RAAS blockers (namely ACE-I and ARBs') influence the change in estimated GFR (eGFR) after administration of contrast media in patients undergoing non-emergent coronary angiography.

Enrollment

100 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Age>18 years
    1. Subjects on chronic therapy with ACE-I and/or ARBs' (confirmed by electronic records in their medical file)
    1. Subjects planned to undergo non-emergent coronary angiography.
    1. Signed informed consent

Exclusion criteria

    1. eGFR<30 ml/min at baseline
    1. Chronic utilization of NSAIDS and Cox-2 selective inhibitors
    1. Chronic treatment with mineralocorticosteroid receptor blocker
    1. Systolic blood pressure<90 mmHg
    1. Planned staged (repeated) procedure within 48 hours
    1. Administration of contrast within 14 days prior to the enrollment
    1. contraindication to stop ACE-I or ARB'S

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 3 patient groups

continue ace-i and arb's versus dicontinue
No Intervention group
group b
Active Comparator group
Treatment:
Drug: stop ace-i/arb 24 h before procedure and restarted 24 hours after the procedure
group c
Active Comparator group
Treatment:
Drug: ACE/ARB stopped 24 hours before procedure and start immediately after

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems